EU RESEARCHERS RECEIVE FUNDING TO DEVELOP MALARIA VACCINE
February 1st, 2007
BY KEITH NUTHALLTHE EUROPEAN Commission has awarded a network of European researchers Euro 2.4 million to chase one of the pharmaceutical industry's Holy Grails: a malaria vaccine. Coordinated by Dutch biotechnology company Crucell, researchers will over three years conduct pre-clinical trials of a peadiatric vaccine where a version of the BCG (tuberculosis) vaccine is the vector for a malaria antigen. The BCG is already given to African children at birth, so the team thinks combining the two is sensible. Participants will study animals to investigate the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.